Drug Profile
Research programme: ghrelin modulators - 7TM Pharma
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator 7TM Pharma
- Class
- Mechanism of Action Ghrelin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cachexia; Gastroparesis; Obesity; Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cachexia in Denmark
- 16 Jul 2016 No recent reports of development identified for research development in Gastroparesis in Denmark
- 16 Jul 2016 No recent reports of development identified for research development in Obesity in Denmark